Biotech SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigations of ANCN, JWS, GXGX, and ALSK Mergers January 26, 2021
Biotech FBIO Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Fortress Biotech, Inc. Investors of Class Action and Lead Plaintiff Deadline: January 26, 2021 January 26, 2021
Biotech Cardiff Oncology Receives “Study May Proceed” from FDA to Initiate Phase 2 Trial of Onvansertib in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) January 26, 2021
Biotech Galmed Pharmaceuticals Announces Upcoming Publication in JHEP Reports of New Data Supporting Aramchol’s Novel Anti-Fibrotic Mechanism of Action January 26, 2021
Biotech Entasis Therapeutics Announces Sulbactam-Durlobactam Expanded Access Program for Patients in the U.S. January 26, 2021
Biotech New Research Published in Toxicology in Vitro Provides Insight Into the Hepatotoxicity of DHODH Inhibitors Suggesting ASLAN003 Has the Potential to Be Best-In-Class January 26, 2021
Biotech AzurRx BioPharma Adds Two New Clinical Trial Sites in Europe for Phase 2b OPTION 2 Extension Study of MS1819 Immediate-Release Capsules in Cystic Fibrosis Patients January 26, 2021
Biotech Eloxx Announces Publication of Scientific Manuscript on ELX-02 in the Journal of Clinical Pharmacology in Drug Development January 26, 2021
Search
Biotech
January 26, 2021
January 26, 2021
January 26, 2021
January 26, 2021
January 26, 2021
January 26, 2021
January 26, 2021
January 26, 2021
January 26, 2021
January 26, 2021
